The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124093225 12409322 5 F 20160518 20160913 20160526 20160920 PER US-ALEXION-A201603801 ALEXION 0.00 F Y 0.00000 20160920 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124093225 12409322 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) UNK U T2-AE7318B01 125166 CONCENTRATE FOR SOLUTION FOR INFUSION

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124093225 12409322 1 Paroxysmal nocturnal haemoglobinuria

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
124093225 12409322 Aggression
124093225 12409322 Alopecia
124093225 12409322 Blood calcium decreased
124093225 12409322 Blood calcium increased
124093225 12409322 Contusion
124093225 12409322 Fluid retention
124093225 12409322 Pain
124093225 12409322 Protein total increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found